Total Payments
$19,702
2024 Payments
$2,609
Companies
56
Transactions
1,189
Medicare Patients
1,546
Medicare Billing
$259,708
Payment Breakdown by Category
Food & Beverage$18,933 (96.1%)
Other$434.79 (2.2%)
Education$334.53 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,933 | 1,152 | 96.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $434.79 | 24 | 2.2% |
| Education | $334.53 | 13 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,625 | 102 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,493 | 93 | $0 (2022) |
| ABBVIE INC. | $1,298 | 89 | $0 (2024) |
| Biogen, Inc. | $1,119 | 114 | $0 (2023) |
| EMD Serono, Inc. | $1,030 | 65 | $0 (2024) |
| GENZYME CORPORATION | $966.58 | 55 | $0 (2023) |
| SK Life Science, Inc. | $854.49 | 56 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $790.46 | 42 | $0 (2024) |
| Lundbeck LLC | $728.85 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $626.66 | 38 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,609 | 132 | ABBVIE INC. ($307.36) |
| 2023 | $3,065 | 162 | Sumitomo Pharma America, Inc. ($523.48) |
| 2022 | $3,053 | 183 | Sunovion Pharmaceuticals Inc. ($429.26) |
| 2021 | $2,468 | 154 | AbbVie Inc. ($278.91) |
| 2020 | $2,103 | 117 | Sunovion Pharmaceuticals Inc. ($328.18) |
| 2019 | $2,379 | 144 | Novartis Pharmaceuticals Corporation ($351.75) |
| 2018 | $2,096 | 161 | Lundbeck LLC ($271.61) |
| 2017 | $1,929 | 136 | Teva Pharmaceuticals USA, Inc. ($404.56) |
All Payment Transactions
1,189 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.70 | General |
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.47 | General |
| 11/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.31 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neurology | ||||||
| 10/28/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Neurology | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: PAIN | ||||||
| 10/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological), INBRIJA | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Musculoskeletal | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: PAIN | ||||||
| 10/14/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/10/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.40 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 369 | 640 | $245,346 | $66,834 |
| 2022 | 8 | 464 | 750 | $283,495 | $79,203 |
| 2021 | 7 | 369 | 522 | $190,195 | $57,042 |
| 2020 | 6 | 344 | 583 | $206,750 | $56,629 |
Total Patients
1,546
Total Services
2,495
Medicare Billing
$259,708
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 399 | $102,500 | $32,214 | 31.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 51 | 52 | $58,600 | $16,527 | 28.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 49 | 104 | $28,620 | $7,530 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $15,226 | $4,429 | 29.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 26 | 26 | $19,500 | $3,135 | 16.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 21 | 22 | $20,900 | $2,997 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 209 | 446 | $111,500 | $34,561 | 31.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 71 | 71 | $78,100 | $22,957 | 29.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 54 | 102 | $28,050 | $7,565 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $24,885 | $6,768 | 27.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 33 | 33 | $24,750 | $4,118 | 16.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $10,450 | $1,418 | 13.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $3,540 | $1,207 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $2,220 | $607.24 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 168 | 276 | $69,000 | $23,473 | 34.0% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 37 | 37 | $34,500 | $12,292 | 35.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 64 | 64 | $25,280 | $6,970 | 27.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 44 | 88 | $24,200 | $6,775 | 28.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 29 | 29 | $21,750 | $3,728 | 17.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 17 | $5,015 | $2,117 | 42.2% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 11 | 11 | $10,450 | $1,686 | 16.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 172 | 357 | $89,250 | $25,684 | 28.8% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2020 | 38 | 38 | $34,200 | $12,216 | 35.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 56 | 110 | $30,250 | $8,327 | 27.5% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 26 | 26 | $24,700 | $3,958 | 16.0% |
About Dr. Keifong Seeto, MD
Dr. Keifong Seeto, MD is a Neurology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962447730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keifong Seeto, MD has received a total of $19,702 in payments from pharmaceutical and medical device companies, with $2,609 received in 2024. These payments were reported across 1,189 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($18,933).
As a Medicare-enrolled provider, Seeto has provided services to 1,546 Medicare beneficiaries, totaling 2,495 services with total Medicare billing of $259,708. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology, Sleep Medicine
- Location Salem, OR
- Active Since 06/17/2006
- Last Updated 06/24/2014
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962447730
Products in Payments
- APTIOM (Drug) $1,547
- Briviact (Drug) $1,291
- TYSABRI (Biological) $812.25
- NURTEC ODT (Drug) $760.81
- AUBAGIO (Drug) $744.48
- UBRELVY (Drug) $717.36
- ZEPOSIA (Drug) $644.37
- RYTARY (Drug) $616.97
- QULIPTA (Drug) $591.22
- KYNMOBI (Drug) $522.17
- Ponvory (Drug) $388.63
- Rebif (Biological) $387.17
- OXTELLAR XR (Drug) $380.87
- Aimovig (Biological) $358.94
- INBRIJA (Drug) $351.56
- NORTHERA (Drug) $327.43
- EMGALITY (Drug) $296.18
- NUPLAZID (Drug) $291.18
- Fycompa (Drug) $285.89
- VYEPTI (Biological) $260.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Salem
Timothy Hormel, Md, MD
Neurology — Payments: $92,423
Neurology $92,423
Chaohua Yan, M.d, M.D
Neurology — Payments: $8,800
Neurology $8,800
Daniel Chen, Md, MD
Neurology — Payments: $4,944
Neurology $4,944
Seymur Gahramanov, M.d, M.D
Neurology — Payments: $4,684
Neurology $4,684
Dr. Clement Elechi, M.d, M.D
Neurology — Payments: $3,916
Neurology $3,916
Kenten Woolhiser, Md, MD
Neurology — Payments: $3,413
Neurology $3,413